RxLyte LLC ("RxLyte") is committed to ensuring that our website, rxlyte.com, is accessible to everyone, including people with disabilities. We continually improve the user experience for all users and apply relevant accessibility standards.
Conformance Status
We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA. These guidelines explain how to make web content more accessible to people with disabilities. Conformance with these guidelines helps make the web more user-friendly for all people.
Measures We Take
RxLyte takes the following measures to ensure accessibility of our website:
- Include accessibility as part of our design and development practices.
- Provide text alternatives for all non-text content.
- Ensure all functionality is available via keyboard navigation.
- Use semantic HTML to communicate meaning and structure to assistive technologies.
- Maintain sufficient color contrast ratios across all page elements.
- Provide visible focus indicators for all interactive elements.
- Label all form fields with descriptive text visible to screen readers.
- Avoid content that flashes or blinks faster than 3 times per second.
- Ensure all video content includes captions and audio descriptions.
Assistive Technology Support
Our website is designed to be compatible with the following assistive technologies:
- Screen readers: JAWS, NVDA, VoiceOver (iOS/macOS), TalkBack (Android)
- Voice control software: Dragon NaturallySpeaking, Voice Control (macOS/iOS)
- Keyboard navigation: Full site navigable without a mouse
- Browser zoom: Content reflows correctly up to 400% zoom
- High contrast mode: Windows High Contrast mode supported
Known Limitations
While we strive for full accessibility, some content may not yet fully conform to WCAG 2.1 AA. We are actively working to address the following:
- Some older PDF documents may lack full accessibility tagging. We are converting these to accessible formats.
- Third-party embedded content (e.g., payment processors) may have accessibility limitations outside our direct control. We notify our vendors of accessibility requirements.
Prescription & Medication Accessibility Services
We recognize that our customers may need accommodation when managing prescriptions. We offer:
- Large-print prescription labels — available on request at no charge
- Braille prescription information — available on request, allow 5–7 business days
- Easy-open (non-child-resistant) caps — available on request for all medications
- Telephone pharmacy services — all services available by phone at 1-800-759-5983
- Language assistance — pharmacist interpretation services available
Feedback & Contact
We welcome your feedback on the accessibility of RxLyte. Please let us know if you encounter barriers:
Phone: 1-800-759-5983 (Mon–Fri 9am–6pm ET, Sat 10am–2pm ET)
Email: accessibility@rxlyte.com
Mail: RxLyte LLC, Accessibility Team, [Address], United States
We try to respond to accessibility feedback within 2 business days.
Formal Complaints
If you are not satisfied with our response, you may contact the relevant enforcement authority. In the United States, individuals with disabilities are protected under the Americans with Disabilities Act (ADA) and Section 508 of the Rehabilitation Act.
Technical Specifications
Our website relies on the following technologies for conformance:
- HTML5, CSS3, and WAI-ARIA (Accessible Rich Internet Applications)
- JavaScript with progressive enhancement
- Structured data and semantic markup
This accessibility statement was last reviewed and updated on June 14, 2026. We assess the accessibility of our site on an ongoing basis.